Injectable Lipid Emulsions-Advancements, Opportunities and Challenges

被引:173
作者
Hippalgaonkar, Ketan [2 ]
Majumdar, Soumyajit [2 ,3 ]
Kansara, Viral [1 ]
机构
[1] Merck Sharp & Dohme Corp, RNAi Delivery & Proc Dev, Biol & Vaccines, West Point, PA 19486 USA
[2] Univ Mississippi, Dept Pharmaceut, Oxford, MS 38677 USA
[3] Univ Mississippi, Pharmaceut Sci Res Inst, Oxford, MS 38677 USA
来源
AAPS PHARMSCITECH | 2010年 / 11卷 / 04期
关键词
biodisposition; lipid emulsions; microfluidization; parenteral formulations; sterilization; MEDIUM-CHAIN TRIGLYCERIDES; TOTAL PARENTERAL-NUTRITION; OIL-IN-WATER; CHOLESTEROL-RICH MICROEMULSION; CRITICALLY-ILL PATIENTS; DRUG-CARRIER EMULSIONS; FAT EMULSIONS; LIPOPHILIC DRUGS; PHYSICOCHEMICAL PROPERTIES; SUBMICRON EMULSIONS;
D O I
10.1208/s12249-010-9526-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Injectable lipid emulsions, for decades, have been clinically used as an energy source for hospitalized patients by providing essential fatty acids and vitamins. Recent interest in utilizing lipid emulsions for delivering lipid soluble therapeutic agents, intravenously, has been continuously growing due to the biocompatible nature of the lipid-based delivery systems. Advancements in the area of novel lipids (olive oil and fish oil) have opened a new area for future clinical application of lipid-based injectable delivery systems that may provide a better safety profile over traditionally used long- and medium-chain triglycerides to critically ill patients. Formulation components and process parameters play critical role in the success of lipid injectable emulsions as drug delivery vehicles and hence need to be well integrated in the formulation development strategies. Physico-chemical properties of active therapeutic agents significantly impact pharmacokinetics and tissue disposition following intravenous administration of drug-containing lipid emulsion and hence need special attention while selecting such delivery vehicles. In summary, this review provides a broad overview of recent advancements in the field of novel lipids, opportunities for intravenous drug delivery, and challenges associated with injectable lipid emulsions.
引用
收藏
页码:1526 / 1540
页数:15
相关论文
共 159 条
[21]  
Chidambaram N, 1999, AAPS PHARMSCI, V1
[22]  
CHIDAMBARAM N, 2005, INJECTABLE DISPERSED, P213
[23]   Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system [J].
Chung, H ;
Kim, TW ;
Kwon, M ;
Kwon, IC ;
Jeong, SY .
JOURNAL OF CONTROLLED RELEASE, 2001, 71 (03) :339-350
[24]   PLASMA-CLEARANCE OF EMULSIFIED TRIOLEIN IN CONSCIOUS RATS - EFFECTS OF PHOSPHATIDYLCHOLINE SPECIES, CHOLESTEROL CONTENT AND EMULSION SURFACE PHYSICAL STATE [J].
CLARK, SB ;
DERKSEN, A ;
SMALL, DM .
EXPERIMENTAL PHYSIOLOGY, 1991, 76 (01) :39-52
[25]   PHOSPHATIDYLCHOLINE COMPOSITION OF EMULSIONS INFLUENCES TRIACYLGLYCEROL LIPOLYSIS AND CLEARANCE FROM PLASMA [J].
CLARK, SB ;
DERKSEN, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 920 (01) :37-46
[26]   PHYTOSTEROLEMIA IN CHILDREN WITH PARENTERAL-NUTRITION ASSOCIATED CHOLESTATIC LIVER-DISEASE [J].
CLAYTON, PT ;
BOWRON, A ;
MILLS, KA ;
MASSOUD, A ;
CASTEELS, M ;
MILLA, PJ .
GASTROENTEROLOGY, 1993, 105 (06) :1806-1813
[27]  
COLLINS-GOLD L C, 1990, Advanced Drug Delivery Reviews, V5, P189, DOI 10.1016/0169-409X(90)90016-L
[28]   Tocol emulsions for drug solubilization and parenteral delivery [J].
Constantinides, PP ;
Tustian, A ;
Kessler, DR .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (09) :1243-1255
[29]   Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel [J].
Constantinides, PP ;
Lambert, KJ ;
Tustian, AK ;
Schneider, B ;
Lalji, S ;
Ma, WW ;
Wentzel, B ;
Kessler, D ;
Worah, D ;
Quay, SC .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :175-182
[30]   Fish Oil-Based Lipid Emulsions Prevent and Reverse Parenteral Nutrition-Associated Liver Disease: The Boston Experience [J].
de Meijer, Vincent E. ;
Gura, Kathleen M. ;
Le, Hau D. ;
Meisel, Jonathan A. ;
Puder, Mark .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2009, 33 (05) :541-547